Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

229
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
229
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.2K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Training Physician Assistant Students in Ultrasound-Guided Knee Arthrocentesis Using Formalin-Embalmed Cadavers.

The journal of physician assistant education : the official journal of the Physician Assistant Education Association·2026
Same author

Special approach of droplet digital polymerase chain reaction (ddPCR) for transgene stability of a Chinese hamster ovary (CHO) cell line.

BioTechniques·2026
Same author

Aggregating and analysing clinical trials data from multiple public registers using R package ctrdata.

Research synthesis methods·2026
Same author

Dual-drug releasing PEG-PLA hydrogels with tunable degradation for sustained local analgesia and anti-inflammatory therapy in a rat fracture/osteotomy model.

Biomaterials·2026
Same author

Advancing pharmacogenomics in medicines regulation and clinical practice: a call for collaborative action.

Nature reviews. Drug discovery·2025
Same author

Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative Study.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2025

相关实验视频

Updated: Jan 13, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K

从创新到安全有效的药物的快速途径

Peter Arlett1, Falk Ehmann1, Ralf Herold1

  • 1European Medicines Agency, Amsterdam, The Netherlands.

Clinical pharmacology and therapeutics
|October 28, 2025
PubMed
概括

本文概述了加速药物开发的愿景,强调监管机构,行业和患者之间的合作. 目标是确保科学进步成为可访问的新药,以满足未满足的医疗需求.

更多相关视频

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.6K
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.7K

相关实验视频

Last Updated: Jan 13, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.6K
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.7K

科学领域:

  • 监管科学 监管科学
  • 药品开发 药品开发
  • 药理学创新 药理学创新

背景情况:

  • 尽管取得了进展,但医疗需求仍未得到满足,特别是在罕见病,儿科和服务不足的人群中.
  • 药理学,技术和监管方面的创新为新疗法提供了希望.
  • 确保科学进步转化为可用的,有效的药物至关重要.

研究的目的:

  • 为加速安全有效药物的开发提出一个愿景.
  • 突出监管机构,学术界,工业界,患者和医疗保健专业人员之间的合作的重要性.
  • 概述监管生态系统未来防范的战略.

主要方法:

  • 欧洲药物管理局 (EMA) 与利益相关者合作.
  • 战略举措和具体例子说明了这一过程.
  • 专注于监管科学的不断演变和以患者为中心的证据生成.

主要成果:

  • 欧洲药物管理局支持监管科学发展.
  • 促进了以患者为中心的证据生成和药物评估的改进.
  • 展望未来的倡议监测和检查创新发展.

结论:

  • 持续透明的合作是加速药物可用性的关键.
  • 监管生态系统的未来保护确保科学进步带来更好的健康结果.
  • 该愿景旨在将创新转化为为患者提供有意义的健康益处.